Showing results (1-10 of 534) with videos related to
Sort By:
Pageof 54
Leukemia Research|March 22, 2003
Commentary: effect of flavonoids on normal and leukemic cellsStefan Faderl, Zeev EstrovLeukemia & Lymphoma|April 6, 2004
Hematopoietic recovery following induction therapy of acute leukemias: prognostic implications and a new look at the definition of remissionStefan Faderl, Zeev EstrovLeukemia Research|December 6, 2001
Shift of immunoglobulin phenotypes in B-cell precursor cell linesStefan Faderl, Zeev EstrovBritish Journal of Haematology|June 13, 2002
Time to platelet recovery predicts outcome of patients with de novo acute lymphoblastic leukaemia who have achieved a complete remissionStefan Faderl, Peter F Thall, Hagop M Kantarjian, et al.Anticancer Research|September 15, 2005
WP-1034, a novel JAK-STAT inhibitor, with proapoptotic and antileukemic activity in acute myeloid leukemia (AML)Stefan Faderl, Alessandra Ferrajoli, David Harris, et al.Leukemia Research|July 11, 2006
Atiprimod blocks phosphorylation of JAK-STAT and inhibits proliferation of acute myeloid leukemia (AML) cellsStefan Faderl, Alessandra Ferrajoli, David Harris, et al.Leukemia Research|January 23, 2003
N-(4-Hydroxylphenyl)retinamide (fenretinide, 4-HPR), a retinoid compound with antileukemic and proapoptotic activity in acute lymphoblastic leukemia (ALL)Stefan Faderl, Reuben Lotan, Hagop M Kantarjian, et al.Blood|March 29, 2003
Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces antiapoptotic and proapoptotic signals in acute myeloid leukemiaStefan Faderl, David Harris, Quin Van, et al.International Journal of Cancer|January 3, 2013
Is acute myeloid leukemia a liquid tumor?Maro Ohanian, Stefan Faderl, Farhad Ravandi, et al.International Journal of Hematology|April 3, 2009
Incidence of extramedullary disease in patients with acute promyelocytic leukemia: a single-institution experienceArturo Vega-Ruiz, Stefan Faderl, Zeev Estrov, et al.Pageof 54